Page 4 - Shivam Tyagi

SAIL, NMDC are down up to 9% in 1 month; is it time to buy steel stocks?

Domestic steel spread is at Rs 24,330 per tonne ( the lowest since March 2024) and the price of hot rolled coil (HRC) is at Rs 51,370 per tonne (the lowest since December 2020), said Dixit

Stocks to watch on Aug 19: Piramal Ent, Jubilant Pharmova, Urja Global

Stocks to watch on August 19: The promoters of the company have announced that on August 16, 2024, an entity within the Promoter Group acquired 616,615 equity shares of Piramal Enterprises

Post solid Q1, Apollo Hospitals on track for all-round growth, say analysts

Shares of Apollo Hospitals Enterprise (AHEL) rose 2.92 per cent to Rs 6,711.95 per share on the BSE in Friday's early morning trade

Ipca Labs may outpace past 5-year growth ahead, analysts say buy the dips

Shares of Ipca Labs slipped 2.82 per cent to Rs 1312.55 per share on the BSE in Friday's early morning trade

Aurobindo Pharma hits lifetime high as analysts make bull case on growth

Shares of Aurobindo Pharmaceuticals soared as much as 4.96 per cent, hitting their all time high at Rs 1532.85 per share on the BSE in Tuesday's intraday trade

Here's why Balkrishna Industries slid 10% despite strong Q1 earnings

Balkrishna Industries, a leading off-highway tyre manufacturer, announced a 47.6 per cent increase in net profit for the first quarter ending June 30, 2024

Analysts wary of Zydus Life's US sales post FY25, valuations; stock down 5%

Shares of Zydus lifesciences slipped 5.3 per cent to Rs 1232.40 per share on the BSE in Monday's early morning trade

Brokerages hike target for Inox Wind, expect strong execution; stock up 19%

Shares of Inox Wind surged up to 9 per cent at Rs 189.90 per share on the BSE in Monday's intraday trade

Info Edge stock rallies 5% on steady Q1 show; matrimony biz grows 38% YoY

Info Edge stock surged up to 4.84 per cent at Rs 7,249.95 per share on the BSE in Friday's intraday deals

Lupin stock soars: Analysts bullish on growth but valuation may cap upside

Brokerages sang in unison about Lupin's growth outlook but stayed divided on the valuation front with many calling the current trading values - a bit expensive

Alembic Pharma Q1FY25: Profits up 10% YoY at Rs 131 cr; stock slips in red

Shares of Alembic Pharmaceuticals rose 5.38 per cent at Rs 1285.60 per share on the BSE on Thursday ahead of the pharma major's financial performance announcement

Motherson Sumi Wiring deserves rich valuations, say analysts post Q1 show

Analysts believe that Motherson Wiring's Q1 show was muted due to start-up costs of two new plants, resulting in lower-than-estimated growth in profits and operating margins

Nomura eyes three US Fed rate cuts in 2024; RBI likely to go its own way

The brokerage firm in a recent report said that the US Federal Reserve may begin rate cuts as early as next month with a 25 bp cut in September, with following rate cuts in November and December of 25

Stock market crash, Aug 5: What should investors do amid US recession woes?

The D-Street witnessed bloodbath on Monday amid major sell-off by global peers. The Sensex sank to an intraday low of 78,295 points, plunging 2,686 points, while the Nifty plummeted 823 points to 23,8

Titan tanks 8% after tepid Q1FY25 show: Should you buy, sell or hold?

Shares of Titan fell 7.56 to Rs 3,201 per share on the BSE in Monday's intraday deals. This came after the company reported a marginal decline in net profits on a year-on-year (YoY) basis

Earnings growth priced-in Divi's Labs stock, niche biz to expand: Analysts

Analysts say pharmaceutical company's stock fully priced in

Lupin Q1 Preview: Steady US sales, market share gains to boost profits

Brokerage estimates suggest that the pharma major is expected to see strong double-digit growth in the bottom line and single-digit growth in the top line year-on-year (YoY)

Sun Pharma Q1 Preview: R&D spends to hit margins; profits may rise 10%

Brokerages expect a satisfactory quarter for Sun Pharma giant with a steady growth in the topline as well as bottomline on a year-on-year (YoY) basis, however, sequentially the bottomline may get hit

Piramal Pharma Q1FY25 results; Loss improves to Rs 89 cr; shares jump 3%

Shares of Piramal Pharma rose 3.51 per cent, reaching their 52-week high at Rs 172.10 per share on the BSE in Friday''s intraday trade

Dr Reddy's Labs Q1 Preview: Market share loss in products to drag profits

Indian drugmaker, Dr Reddy's Laboratories is all set to deliver its financial performance for the first quarter of financial year 2024-25 (Q1FY25) on Saturday, July 27, 2024